Eli Lilly and Ascidian reach a global agreement to develop RNA exon editing drugs On June 3, 2026, Ascidian Therapeutics announced today that it has reached a global research collaboration and licensing agreement with Ei Lily and Company
The key, though, is restraint
When I evaluate a sweetener for a patient, I run it through five questions rather than one: Does it raise blood sugar and insulin
Interestingly, the World Anti-Doping Agency (WADA) has taken notice
Highmark has created relationships with specialty drug manufacturers who can speed the necessary medications to our members, often at a reduced cost
Studies suggest Carnipure, L-Carnitine can help increase beta-oxidation, burning more fat and producing more energy